Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China

PURPOSE: To evaluate the efficacy and safety of everolimus and sirolimus in patients with tuberous sclerosis complex-associated angiomyolipomas (TSC-AML). MATERIALS AND METHODS: We performed a multi-institutional retrospective study of TSC-AML patients treated with oral everolimus 10 mg or sirolimus...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Cong, Zhang, Yu-Shi, Zhang, Ming-Xin, Chen, Min-Feng, Li, Yuan, Qi, Lin, Li, Han-Zhong, Zu, Xiong-Bin, Cai, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254951/
https://www.ncbi.nlm.nih.gov/pubmed/34217357
http://dx.doi.org/10.1186/s13023-021-01932-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254951/
https://www.ncbi.nlm.nih.gov/pubmed/34217357
http://dx.doi.org/10.1186/s13023-021-01932-z

Ejemplares similares